POINT Biopharma Global Inc. Common Stock
PNT
PNT: POINT Biopharma Global Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Its product pipeline includes PNT2002; PNT2004; PNT2003; PNT2001 and others.
moreShow PNT Financials
Recent trades of PNT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PNT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on PNT's company Twitter account
Number of mentions of PNT in WallStreetBets Daily Discussion
Recent insights relating to PNT
Recent picks made for PNT stock on CNBC
ETFs with the largest estimated holdings in PNT
Flights by private jets registered to PNT